The promising compound PROTAC‐7 (Table 1 and Figure 3; CRBN‐1/CRBN‐2) could effectively induce the degradation of ALK with a DC50 value of 27 nM in H3122 NSCLC cell line. Here, ALK is linked to non-small cell lung carcinoma.